Methylprednisolone , compared with placebo , did not reduce the risk of death at @ days ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- patients ; relative risk -LSB- RR -RSB- @ , @ % CI @-@ , p = @ ) or the risk of death or major morbidity ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ; RR @ , @ % CI @-@ , p = @ ) .